miércoles, 29 de abril de 2015

Postmortem Stability of Ebola Virus - Volume 21, Number 5—May 2015 - Emerging Infectious Disease journal - CDC

full-text ►

Postmortem Stability of Ebola Virus - Volume 21, Number 5—May 2015 - Emerging Infectious Disease journal - CDC





Volume 21, Number 5—May 2015

Dispatch

Postmortem Stability of Ebola Virus

Joseph Prescott, Trenton Bushmaker, Robert Fischer, Kerri Miazgowicz, Seth Judson, and Vincent J. MunsterComments to Author 
Author affiliations: National Institutes of Health, Hamilton, Montana, USA

Abstract

The ongoing Ebola virus outbreak in West Africa has highlighted questions regarding stability of the virus and detection of RNA from corpses. We used Ebola virus–infected macaques to model humans who died of Ebola virus disease. Viable virus was isolated <7 days posteuthanasia; viral RNA was detectable for 10 weeks.
The ongoing outbreak of Ebola virus (EBOV) infection in West Africa highlights several questions, including fundamental questions surrounding human-to-human transmission and stability of the virus. More than 20,000 cases of EBOV disease (EVD) have been reported, and >8,000 deaths have been documented (1). Human-to-human transmission is the principal feature in EBOV outbreaks; virus is transmitted from symptomatic persons or contaminated corpses or by contact with objects acting as fomites (2). Contact with corpses during mourning and funeral practices, which can include bathing the body and rinsing family members with the water, or during the removal and transportation of bodies by burial teams has resulted in numerous infections (3).
Assessing the stability of corpse-associated virus and determining the most efficient sampling methods for diagnostics will clarify the safest practices for handling bodies and the best methods for determining whether a person has died of EVD and presents a risk for transmission. To facilitate diagnostic efforts, we studied nonhuman primates who died of EVD to examine stability of the virus within tissues and on body surfaces to determine the potential for transmission, and the presence of viral RNA associated with corpses.

Dr. Prescott is a research fellow in the Virus Ecology Unit at Rocky Mountain Laboratories, Hamilton, Montana. He is currently involved in the Ebola virus outbreak at the combined Centers for Disease Control and Prevention/National Institutes of Health diagnostic laboratory, Monrovia, Liberia. His research interests include the immune response, transmission, and modeling of viral hemorrhagic fevers.

Acknowledgments

We thank Darryl Falzarano and Andrea Marzi for use of animal carcasses upon completion of their studies and Anita Mora for providing assistance with graphics.
This study was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

References

  1. Centers for Disease Control and Prevention. Ebola hemorrhagic fever [cited 2015 Jan 3]. http://www.cdc.gov.ezproxy.nihlibrary.nih.gov/vhf/ebola/
  2. Dowell SFMukunu RKsiazek TGKhan ASRollin PEPeters CJTransmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis1999;179(Suppl 1):S8791 . DOIPubMed
  3. Khan ASTshioko FKHeymann DLLe Guenno BNabeth PKerstiëns BThe reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis1999;179(Suppl 1):S7686DOIPubMed
  4. Hoenen TGroseth AFeldmann FMarzi AEbihara HKobinger GComplete genome sequences of three Ebola virus isolates from the 2014 outbreak in West Africa. Genome Announc. 2014;2:e01331–14.
  5. Ng SCowling BAssociation between temperature, humidity and ebolavirus disease outbreaks in Africa, 1976 to 2014. Euro Surveill.2014;19:20892 .PubMed
  6. Marzi AEbihara HCallison JGroseth AWilliams KJGeisbert TWVesicular stomatitis virus–based Ebola vaccines with improved cross-protective efficacy. J Infect Dis2011;204(Suppl 3):S106674DOIPubMed
  7. Ebihara HRockx BMarzi AFeldmann FHaddock EBrining DHost response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus. J Infect Dis2011;204(Suppl 3):S9919DOIPubMed
  8. Finney DJ. Statistical method in biological assay. New York: Macmillian Publishing Co., Inc.; 1978. p. 394–8.
  9. Towner JSRollin PEBausch DGSanchez ACrary SMVincent MRapid diagnosis of Ebola hemorrhagic fever by reverse transcription–PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol2004;78:433041DOIPubMed
  10. Bausch DGTowner JSDowell SFKaducu FLukwiya MSanchez AAssessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis2007;196(Suppl 2):S1427DOIPubMed
  11. Formenty PLeroy EMEpelboin ALibama FLenzi MSudeck HDetection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis2006;42:15216DOIPubMed
  12. Grolla AJones SMFernando LStrong JEStröher UMöller PThe use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg outbreak in Angola. PLoS Negl Trop Dis2011;5:e1183DOIPubMed

Figures

Suggested citation for this article: Prescott J, Bushmaker T, Fischer R, Miazgowicz K, Judson S, Munster VJ. Postmortem stability of Ebola virus. Emerg Infect Dis. 2015 May [date cited]. http://dx.doi.org/10.3201/eid2105.150041
DOI: 10.3201/eid2105.150041

No hay comentarios:

Publicar un comentario